Personalised Medicine Market in Europe

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

The following 44 slides provide an analysis of key trends and issues of the personalised medicine industry globally with a key focus on issues pertaining to Europe. The study provides an overview of the key drivers, restraints and challenges that the personalised healthcare industry faces. It also provides a list of over 100 companies and their areas of focus in the personalised medicine ambit in addition to 30 deals.

Table of Contents

Personalised Medicine Market in Europe, Personalised Medicine - OverviewOverview of Personalised MedicineThe Blockbuster ModelIntroduction to Personalised MedicineRole of Biomarkers in Personalised MedicineDrug Development and Companion Diagnostic Development PathwaysPersonalised Medicine Market in Europe, Analysis of Stakeholders of Personalised MedicineStakeholder AnalysisKey Stakeholders and BenefitsAnalysis of Stakeholder PrioritiesComparison of Value of Drug Versus Diagnostic to StakeholdersPersonalised Medicine Market in Europe, Drivers Restraints and Challenges of Personalised MedicineDrivers Restraints and ChallengesBenefits and DriversRestraints and ChallengesPersonalised Medicine Market in Europe, The Issues of Personalised Medicine in EuropePersonalised Medicine in EuropeMain Challenges to Personalised Medicine in EURegulatory and Reimbursement Issues in EuropeRecent Initiatives in Personalised Medicine in EuropePersonalised Medicine Market in Europe, Analysis of Global Alliances and List of Companies by Type of FocusCompanies List and AlliancesGlobal List of Companies by Type of FocusGlobal Pharma Diagnostic Alliances between 2000 and 2010Key ObservationsMajor Themes that have Emerged in Personalised MedicineAbout Frost & Sullivan




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 13-Dec-17

Region : North America

Release Date : 13-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.